Stereoelectroencephalography-guided radiofrequency thermocoagulation of the epileptogenic zone: a potential treatment and prognostic indicator for subsequent excision surgery
Acta Neurochirurgica · 13.05.2024 · 166 (1)
DOI: 10.1007/s00701-024-06106-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neurochirurgica, online erschienen am 13.05.2024. Verfasst von Chuan Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical College of Neurology, Neurosurgery and Neurorehabilitation, Tianjin Medical University, Tianjin, 300350, China. Hauptthemen laut MEDLINE: Electrocoagulation, Electroencephalography, Drug Resistant Epilepsy, Epilepsies, Partial. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To evaluate the safety and efficacy of stereoelectroencephalography (SEEG)-guided radiofrequency thermocoagulation (RFTC) for drug-resistant focal epilepsy and investigate the relationship between post-RFTC remission duration and delayed excision surgery effectiveness. METHODS: We conducted a retrospective analysis of 43 patients with drug-resistant focal epilepsy who underwent RFTC via SEEG electrodes. After excluding three, the remaining 40 were classified into subgroups based on procedures and outcomes. Twenty-four patients (60%) underwent a secondary excision surgery. We determined the predictive value of RFTC outcome upon subsequent surgical outcome by categorizing the delayed secondary surgery outcome as success (Engel I/II) versus failure (Engel III/IV). Demographic information, epilepsy characteristics, and the duration of seizure freedom after RFTC were assessed. RESULTS: Among 40 patients, 20% achieved Engel class I with RFTC alone, while 24 underwent delayed secondary excision surgery. Overall, 41.7% attained Engel class I, with a 66.7% success rate combining RFTC with delayed surgery. Seizure freedom duration was significantly longer in the success group (mean 4.9 months, SD = 2.7) versus the failure group (mean 1.9 months, SD = 1.1; P = 0.007). A higher proportion of RFTC-only and delayed surgical success group patients had preoperative lesional findings (p = 0.01), correlating with a longer time to seizure recurrence (p < 0.05). Transient postoperative complications occurred in 10%, resolving within a year. CONCLUSION: This study demonstrates that SEEG-guided RFTC is a safe and potential treatment option for patients with drug-resistant focal epilepsy. A prolonged duration of seizure freedom following RFTC may serve as a predictive marker for the success of subsequent excision surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical College of Neurology, Neurosurgery and Neurorehabilitation, Tianjin Medical University, Tianjin, 300350, China.
- Department of Neurosurgery, Huanhu Hospital, Tianjin University, Tianjin, 300350, China.
- Department of Neurosurgery, Huanhu Hospital, Tianjin University, Tianjin, 300350, China. yinshaoyaa@163.com.
ORCID-Profile: Chuan Du, Shaoya Yin
Zitieren
APA
Du, C., Jin, W., Wang, L., Yan, J., Li, G., Wu, Y., Zhao, G., Cui, D., & Yin, S. (2024). Stereoelectroencephalography-guided radiofrequency thermocoagulation of the epileptogenic zone: a potential treatment and prognostic indicator for subsequent excision surgery. Acta Neurochirurgica, 166(1). https://doi.org/10.1007/s00701-024-06106-x
Vancouver
Du C, Jin W, Wang L, Yan J, Li G, Wu Y, et al. Stereoelectroencephalography-guided radiofrequency thermocoagulation of the epileptogenic zone: a potential treatment and prognostic indicator for subsequent excision surgery. Acta Neurochirurgica. 2024;166(1). doi:10.1007/s00701-024-06106-x
BibTeX
@article{Du2024,
author = {Du, Chuan and Jin, Weipeng and Wang, Le and Yan, Jingtao and Li, Guangfeng and Wu, Yuzhang and Zhao, Guangrui and Cui, Deqiu and Yin, Shaoya},
title = {Stereoelectroencephalography-guided radiofrequency thermocoagulation of the epileptogenic zone: a potential treatment and prognostic indicator for subsequent excision surgery},
journal = {Acta Neurochirurgica},
year = {2024},
volume = {166},
number = {1},
doi = {10.1007/s00701-024-06106-x}
}
EUVIMED